Novel carbapenemase gene NDM-12 detected in Kathmandu- E. coli MDR study

PhD candidate Basudah Shrestha gave an excellent presentation of her initial findings at a symposium celebrating the IOM, TU  collaboration with NCGM, Tokyo, Japan on Dec 5th 2014 at the Institute of Medicine, KMD.

250 multi-drug resistant E. coli isolates were characterized. The isolates were predominantly from urine specimens and were collected at Kathmandu Model Hospital from December 2013 to September 2014.  Phenotypic aminoglycoside and TGC resistance (ESBL) was common and 39 isolates were carbapenem-resistant. 82% of these 39 had one of 6 different NDM variants present, including a new variant, NDM-12, that was characterized in detail.  Ref: Tada T. et. al,. Antimicrob. Agents Chemother. 2014; 58(10): 6302-6305.

This is an important study, highlighting very concerning levels of multi-drug resistance in E. coli in KMD that will only be addressed through concerted collective action to reduce and rationalise antibiotic use and improve/implement effective infection control in hospitals and community.

About mdjkf

Microbiologist and Infectious Diseases Physician
This entry was posted in A/m resistance and tagged , , , , , , . Bookmark the permalink.

2 Responses to Novel carbapenemase gene NDM-12 detected in Kathmandu- E. coli MDR study

  1. Prof Dr Manen P Gorkhaly says:

    Thanks a lot. very interesting information. Can i get the full article please ? Prof Dr Manen Gorkhaly

    Like

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s